Navigation Links
Navigable nanotransport

To accurately transport pharmaceutical agents to their specific target organs or cell types, you need a good carrier: nanoscopic capsules with surface elements that can "recognize" the target in question could do the trick.

To date, all methods for the production of such tiny capsules require preorganized structures or "molds" to shape hollow spheres and most methods require a lengthy, tedious synthetic or purification procedure. Korean researchers led by Kimoon Kim have now developed a very simple novel approach for the direct production of polymeric nanocapsules. As described in the journal Angewandte Chemie, this method is generally applicable to any monomers as long as they have a flat core and multiple polymerizable groups at the periphery. Additionally, if building block are chosen that are able to bind specific (bio)molecules very tightly, the surface of the capsule can be easily decorated with species that are recognized by cells, showing the transporter the way to reach its goal, such as a tumor cell.

To demonstrate the power of their new concept, Kim and his team chose rigid, disk-shaped monomers equipped with a ring of special molecular "hooks" that can be activated by UV light. When a solution containing these disks is irradiated, the hooks grab on to each other, linking the disks into little, two-dimensional "patches" that in turn hook on to other patches. Once they reach a certain size, the patches bend around and close off to form hollow spheres, which can then be filled with guest molecules. The size of the spheres is very uniform and depends largely on the solvent in which the linking reaction takes place. The researchers used this method to produce capsules with diameters ranging from 50 to 600 nm.

The little disks used in this process deserve special consideration: Kim and his colleagues chose to use curcurbiturils. These disk-shaped molecules have a cavity at their center. As their shape resembles a hollowed-out pumpkin
'"/>

Source:John Wiley & Sons, Inc.


Page: 1 2

Related biology news :

1. Major new UNC-based drinking water study suggests pregnancy fears may be overstated
2. Major breakthrough in the treatment of cancers and infectious diseases
3. Major advance made on DNA structure
4. Major WHO study concludes calcium supplements can reduce complications during pregnancy
5. Major obesity gene is lost in the shuffle
6. Major initiative proposed to address amphibian crisis
7. Major cancer study aims to identify protein markers for early-stage disease
8. Major link in brain-obesity puzzle found
9. Bioartificial kidney under study at MCG
10. W.M. Keck Foundation funds study of friendly microbes
11. Yellowstone microbes fueled by hydrogen, according to U. of Colorado study

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Navigable nanotransport

(Date:11/30/2009)...port published in the December 2009 print issue of...r type of control over their fertility that women ...s have found how and where androgenic hormones wor... and male fertility. This opens a promising avenue...scovery also offers hope to those who cannot have ...
(Date:11/26/2009)... are some of the Ocean,s most distinctive resident...s strange head shape, says Michelle McComb from F... the shark,s vision. ,Perhaps their visual field h...McComb, giving the sharks excellent stereovision a... there were two schools of thought on this theory....
(Date:11/26/2009)...out in eight European countries has shown that clo... pandemic could have a significant role in reducin... open access journal BMC Infectious Diseases com...nd weekends/holidays, finding that they were reduc...elt and Antwerp University, Belgium, led a team of...
Breaking Biology News(10 mins):Wide heads give hammerheads exceptional stereo view 2School closure could reduce swine flu transmission by 21 percent 2New stem cell identification technology could cure breast cancer 4969 1New stem cell identification technology could cure breast cancer 4969 2First results from major European patient survey show devastating impact of living with breakthrough cancer pain 56899 1First results from major European patient survey show devastating impact of living with breakthrough cancer pain 56899 2ThromboGenics is Shortlisted for 22Biotech Company of the Year 22 and 22Licensing Deal of the Year 22 at Scrip Awards 2009 13998 1ThromboGenics is Shortlisted for 22Biotech Company of the Year 22 and 22Licensing Deal of the Year 22 at Scrip Awards 2009 13998 2ThromboGenics is Shortlisted for 22Biotech Company of the Year 22 and 22Licensing Deal of the Year 22 at Scrip Awards 2009 13998 3
...eir kind, researchers at Rice University and The U...ve determined that carbon nanotubes injected direc...ause no immediate adverse health effects and circu...d by the liver. , The findings are from the first ...on nanotubes, a revolutionary nanomaterial that ma...
...scoveries are named Charlotte, but they are weavin...studies at Texas A&M University have led to th... one species found for the first time in Texas. , ...dation, Henderson, who is earning a master,s degre...ribution and abundance in the 515-acre Lick Creek ...
... of Warwick should have gardeners and commercial g...ic waste composts. The University,s plant research... paper based composts are proving to be a major we...s. , A University of Warwick research team under ...use of composts can reduce the incidence of some i...
Other Biology News:Pure carbon nanotubes pass first in vivo test 2Ground spider diversity studied in research project 2Recycled paper and compost could both be key tools to control plant disease 2
(Date:11/30/2009)...LLE, Md., Nov. 30 Novava...company, announced today that the company will be ...ce 2009 on December 2, 2009 at 12:30 pm local time...rovide an overview of the company,s business strat...g milestones. A link to the live audio only prese...
(Date:11/30/2009)...LLE, Md., Nov. 30 Novava...mpleted enrollment in the Phase II clinical study ...ommended strains) VLP vaccine candidate in healthy...This randomized, double-blind, active-controlled s...unogenicity of two different doses (15 mcg and 60 ...
(Date:11/30/2009)... SHANGHAI, Nov. 30 /PRNewswire-Asia/ -- WuXi Phar...otechnology, and medical-device research and,devel...a and the United States,announced that it had bee...a,2009 list for the fifth consecutive year. The li...China,s technology, media, and telecommunications,...
(Date:11/27/2009)...URHAM, N.C., Nov. 27 Cromoz Inc., ...ater-soluble carbon nanotube-based cancer drug del...e carbon nanotubes, which have functional groups o...r drugs, was developed in partnership with the Ind...on nanotubes serves as a drug delivery vehicle wit...
Breaking Biology Technology:NOVAVAX to Present at the Piper Jaffray 21st Annual Health Care Conference 2NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 2NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 3NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 4WuXi PharmaTech Named in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Year 2North Carolina Based Cromoz Inc. Launches Carbon Nanotechnology for Target Drug Delivery System in Cancer Treatment in Hyderabad, India 2
...n Investment to Finance Growth in Chindex,s Health...ina, BETHESDA, Md., Nov. 7 /Xinhua-PRNewswire/ --...ding independent American provider of Western,heal...lic of China, today,announced that it has agreed t... Management group. The investment will consist of ...
...., Nov. 7 Transgenomic Inc. (OTC,Bulletin Board: ...Transgenomic Inc. Third Quarter 2007 Earnings Rele...ay, November 7, 2007 @ 5:00 p.m. Eastern, Where: ... How: Live over the Internet -- Simply log on...tact: Investor Relations -- 402-452-5400 To acce...
... CA, Nov. 7 /PRNewswire-FirstCall/ - Nventa,Biopha...y financial results,for the third quarter ended Se...herwise, are in Canadian dollars. Nventa reported...r the,three months ended September 30, 2007, compa...are, for the same period in 2006. For the nine,mon...
Other Biology Technology:JPMorgan's Principal Investment Management Group to Invest in Chindex International, Inc. 2JPMorgan's Principal Investment Management Group to Invest in Chindex International, Inc. 3Webcast Alert: Transgenomic Inc. Announces Third Quarter 2007 Earnings Release Conference Call Webcast 2Nventa Biopharmaceuticals Corporation announces third-quarter 2007 financial results 2Nventa Biopharmaceuticals Corporation announces third-quarter 2007 financial results 3Nventa Biopharmaceuticals Corporation announces third-quarter 2007 financial results 4
...dom EVO96R and Freedom EVO384R are fast multi-chan...t, available in three different sizes, with a mult... deliver significant time saving, with true parall...f your assays with the Freedom EVOware program. ...
Bovine Serum, Sterile Filtered from Meridian Life Science, Inc.
Bromophenol Blue sodium salt from Sigma-Aldrich
Blue Magnet from StemCell Technologies, Inc.
Biology Products: